← TrialMatch
HomeTrials

Virtual Reality for Children in Radiotherapy (REVER)

For a young patient, the conditions of proton therapy treatment can be stressful. Adjusting the environment can be a source of avoiding this physical and psychological discomfort impacting the quality of treatment. A fixed, long, uncomfortable position is the main cause of stress, already present due to the cancerous t

Condition(s)Virtual Reality, Proton Therapy, Pediatric Cancer
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryFor a young patient, the conditions of proton therapy treatment can be stressful. Adjusting the environment can be a source of avoiding this physical and psychological discomfort impacting the quality of treatment. A fixed, long, uncomfortable position is the main cause of stress, already present due to the cancerous therapeutic course. It extends the positioning time. For the patient and the optimization of his treatment, solutions must be sought. Relaxation in virtual reality is efficient, simple and non-medicinal and could reduce stress in children and allow irradiation in very good conditions. We will assess the effectiveness of the virtual reality session using objective (placement time, helmet tolerance) and subjective (perceived anxiety via a dedicated questionnaire) criteria. This
Who can participateInclusion Criteria: * Patient treated at the Antoine LACASSAGNE Center for treatment by proton therapy * Age ≥ 7 years old and ≤ 18 years old * Patient, and parents for minor children, having read the information notice and signed the informed consent, * Patient with social security coverage. Exclusion Criteria: * Age \< 7 years old and \> 18 years old, * Patient under general anesthesia, * Patient suffering from wounds or infections in the head, deemed incompatible with the use of the helmet by the investigator, * Patient suffering from respiratory problems, * Patient suffering from a high level of claustrophobia, * Patient followed for a psychiatric pathology, * Patient suffering from unbalanced epilepsy, * Patient suffering from visual (binocular vision) and / or hearing disorders preve
Ages7 Years to 18 Years
SexAll
Lead sponsorCentre Antoine Lacassagne
LocationsNice, France
Start date2021-08-02
NCT IDNCT04934293
Official listinghttps://clinicaltrials.gov/study/NCT04934293

🔍 Search all trials →